肾移植术后晚期Ⅱ类抗体介导性排斥反应的治疗：两例病例报告
Treatment of Late Class II Antibody-Mediated Rejection Status Postkidney Transplantation: Two Case Reports.
作者信息
Siskind Eric, Bhaskaran Madhu, Boctor Fouad, Shah Kavin, Molmenti Ernesto
机构信息
North Shore Long Island Jewish Health System Transplantation Center, Manhasset, New York.
出版信息
Int J Angiol. 2012 Jun;21(2):107-10. doi: 10.1055/s-0032-1315622.
Abstract
We are describing the successful treatment of two cases of late Class II antibody mediated rejection status postkidney transplantation. The first patient was treated with a combination of plasmapheresis, intravenous immunoglobulin (IVIG), and stenting of the transplanted renal artery. The second was treated with IVIG and pulse steroids.
摘要
我们正在描述两例肾移植术后晚期II类抗体介导排斥反应的成功治疗案例。首例患者接受了血浆置换、静脉注射免疫球蛋白（IVIG）以及移植肾动脉支架置入术联合治疗。第二例患者接受了IVIG和冲击剂量类固醇治疗。
相似文献
1
Treatment of Late Class II Antibody-Mediated Rejection Status Postkidney Transplantation: Two Case Reports.肾移植术后晚期Ⅱ类抗体介导性排斥反应的治疗：两例病例报告
Int J Angiol. 2012 Jun;21(2):107-10. doi: 10.1055/s-0032-1315622.
3
Effectiveness of Intravenous Immunoglobulin Plus Plasmapheresis on Antibody-mediated Rejection or Thrombotic Microangiopathy in Iranian Kidney Transplant Recipient.静脉注射免疫球蛋白联合血浆置换对伊朗肾移植受者抗体介导的排斥反应或血栓性微血管病的疗效
Nephrourol Mon. 2015 May 23;7(3):e27073. doi: 10.5812/numonthly.7(3)2015.27073. eCollection 2015 May.
4
Treatment of acute antibody-mediated rejection using bortezomib: a case report.使用硼替佐米治疗急性抗体介导的排斥反应：一例病例报告。
Nephrology (Carlton). 2015 Jul;20 Suppl 2:86-9. doi: 10.1111/nep.12459.
5
Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.
Transplantation. 2000 Sep 27;70(6):887-95. doi: 10.1097/00007890-200009270-00006.
6
Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy.肾移植受者 BK 病毒肾病患者静脉注射免疫球蛋白后发生严重抗体介导的排斥反应。
Transpl Immunol. 2013 Jun;28(4):145-7. doi: 10.1016/j.trim.2013.05.004. Epub 2013 May 15.
7
Acute antibody-mediated rejection in paediatric renal transplant recipients.儿童肾移植受者的急性抗体介导的排斥反应。
Pediatr Nephrol. 2011 Jul;26(7):1149-56. doi: 10.1007/s00467-011-1864-3. Epub 2011 Apr 1.
8
Therapeutic Effect of Plasmapheresis and Intravenous Immunoglobulin in Recipients of Kidney Transplant With High Panel-reactive Antibody Levels: A Single-center Experience.血浆置换和静脉注射免疫球蛋白对高群体反应性抗体水平肾移植受者的治疗效果：单中心经验
Transplant Proc. 2019 Sep;51(7):2254-2256. doi: 10.1016/j.transproceed.2019.04.073.
9
Plasmapheresis, intravenous cytomegalovirus-specific immunoglobulin and reversal of antibody-mediated rejection in a pediatric renal transplant recipient: a case report.
Pediatr Transplant. 1999 May;3(2):146-9. doi: 10.1034/j.1399-3046.1999.00022.x.
10
Repeated cycles of high-dose intravenous immunoglobulin and plasmapheresis for treatment of late antibody-mediated rejection of renal transplants.大剂量静脉注射免疫球蛋白和血浆置换的重复疗程用于治疗肾移植晚期抗体介导的排斥反应。
J Formos Med Assoc. 2016 Oct;115(10):845-852. doi: 10.1016/j.jfma.2016.07.007. Epub 2016 Aug 16.
引用本文的文献
1
Rational clinical trial design for antibody mediated renal allograft injury.抗体介导的肾移植损伤的合理临床研究设计。
Front Biosci (Landmark Ed). 2015 Jan 1;20(4):743-62. doi: 10.2741/4334.
2
Late kidney dysfunction in a kidney transplant recipient.移植肾受者的晚期肾功能障碍。
Clin J Am Soc Nephrol. 2014 Mar;9(3):590-7. doi: 10.2215/CJN.07390713. Epub 2013 Dec 26.
本文引用的文献
1
Antibody-mediated rejection in kidney transplantation: an update.抗体介导的肾移植排斥反应：最新进展。
Expert Opin Pharmacother. 2011 Mar;12(4):579-92. doi: 10.1517/14656566.2011.525219. Epub 2011 Feb 5.
2
Treatment of acute antibody-mediated rejection: a single-center experience.急性抗体介导排斥反应的治疗：单中心经验
Transplant Proc. 2010 Oct;42(8):2848-50. doi: 10.1016/j.transproceed.2010.07.068.
3
Late acute kidney transplant rejection: clinicopathological correlates and response to corticosteroid therapy.晚期急性肾移植排斥反应：临床病理相关性及对皮质类固醇治疗的反应
Transplant Proc. 2009 Dec;41(10):4150-3. doi: 10.1016/j.transproceed.2009.09.074.
4
Accelerated arteriosclerosis: a form of transplant arteriopathy.加速性动脉硬化：一种移植性动脉病。
Curr Opin Organ Transplant. 2010 Feb;15(1):11-5. doi: 10.1097/MOT.0b013e3283342684.
5
Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection.血浆置换/静脉注射免疫球蛋白/抗CD20联合疗法与大剂量静脉注射免疫球蛋白治疗抗体介导性排斥反应的比较
Am J Transplant. 2009 May;9(5):1099-107. doi: 10.1111/j.1600-6143.2009.02591.x.
6
Plasmapheresis and intravenous immunoglobulin in early antibody-mediated rejection of the renal allograft: a single-center experience.血浆置换和静脉注射免疫球蛋白用于肾移植早期抗体介导的排斥反应：单中心经验
Ther Apher Dial. 2009 Apr;13(2):108-12. doi: 10.1111/j.1744-9987.2009.00664.x.
7
Impact of rituximab therapy for treatment of acute humoral rejection.利妥昔单抗治疗急性体液排斥反应的疗效
Clin Transplant. 2009 Jan-Feb;23(1):63-73. doi: 10.1111/j.1399-0012.2008.00902.x.
8
Treatment of antibody-mediated rejection after kidney transplantation.
Transplant Proc. 2008 Jun;40(5):1373-4. doi: 10.1016/j.transproceed.2008.03.160.
9
The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection.
Am J Transplant. 2007 Apr;7(4):842-6. doi: 10.1111/j.1600-6143.2006.01709.x.
10
National conference to assess antibody-mediated rejection in solid organ transplantation.评估实体器官移植中抗体介导排斥反应的全国性会议。
Am J Transplant. 2004 Jul;4(7):1033-41. doi: 10.1111/j.1600-6143.2004.00500.x.
Zotero 插件